GlobalData on MSN

Clarametyx completes enrolment in cystic fibrosis trial

Clarametyx has concluded subject enrolment in its Phase Ib/IIa study of CMTX-101, an immune-enhancing antibody therapy being ...
ascopubs.org

A phase Ib study for MNRP1685A (anti-NRP1) administered intravenously with bevacizumab with or without paclitaxel to patients with advanced solid tumors.

A phase I schedule optimization study of pegylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-l-norleucine (DON) in patients (pts) with advanced solid tumors. This is an ASCO Meeting Abstract from the ...

Satellos reports safety data of SAT-3247 in Duchenne muscular dystrophy trial

Data from the Phase Ia/b study demonstrated that SAT-3247 was well-tolerated and safe with a desirable PK profile.
ascopubs.org

Multicenter phase Ib/II study of biweekly trifluridine/tipiracil with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies ...

A phase I/II study of pexa-vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer: Safety report. This is an ASCO Meeting Abstract from the 2019 ...
Business Wire

Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder

INDIANAPOLIS--(BUSINESS WIRE)--Scioto Biosciences, Inc. announced the beginning of their Phase Ib clinical trial for their lead investigational product SB-121 for the treatment of Autistic Disorder ...